Literature DB >> 30283867

Racial Disparities and the Effect of County Level Income on the Incidence and Survival of Young Men with Anal Cancer.

Markian M Bojko1, Robert J Kucejko1, Juan L Poggio2.   

Abstract

Purpose: Prior studies have identified a racial disparity in incidence and survival of squamous cell carcinoma of the anus (SCCA) in the young African American male population. We aim to determine whether racial disparities are independent of income and urban location.
Methods: The National Cancer Institute's Surveillance of Epidemiology and End Results database was queried for data on patients with SCCA for the years of 2000-2013. Cox regression was used to determine the effect of race, county median family income, rural-urban continuum, and stage of disease on overall survival.
Results: The incidence rate of SCCA was significantly higher in black men <50 years old than in white men. Black race had a hazard ratio of 1.55 (confidence interval [CI] 1.33-1.81) when controlling for age, stage, income, and urban-rural status. Each $10,000 increase in county median family income was protective with a hazard ratio of 0.90 (CI 0.86-0.94). Residence in a metropolitan area did not significantly affect survival. Conclusions: The lower survival of black men <50 years old with SCCA is independent of income, urban location, and stage of disease. Further efforts are needed to target this at-risk population and the authors suggest wide application of previously validated screening programs for anal dysplasia.

Entities:  

Keywords:  anal cancer; incidence and survival; racial disparity; socioeconomic status

Year:  2018        PMID: 30283867      PMCID: PMC6110184          DOI: 10.1089/heq.2018.0018

Source DB:  PubMed          Journal:  Health Equity        ISSN: 2473-1242


Introduction

The incidence rates of anal cancer have been increasing in the United States significantly over the past two decades. The relative risk (RR) for anal cancer in men aged 20–34 years was four times as high as to women of the same age between 1997 and 2009.[1,2] The average annual percentage change in this same age group was 10.7% in men, which was more than double the rate in women at 4.0%. Similarly, the RR for anal cancer in men 35–49 years was almost two and a half times higher that of women. The reason for this disproportionate incidence of anal cancer in these age groups is not well understood in the literature. The unequal incidence is not seen in older patients. These reports demonstrate that young men have emerged as the most vulnerable demographic subgroup at risk for developing anal cancer. Prior research suggests that the increased incidence seen in the young male population is due to changing sexual practices.[1] Approximately 85% of the anal cancer cases are squamous cell carcinoma of the anus (SCCA): a disease believed to be etiologically associated with human papillomavirus (HPV) infection. The risk factors for contraction of HPV include lifetime number of sexual partners, sexual practices, race, age, same-sex sexual behavior, and underlying human immunodeficiency virus (HIV) infection. Thus, among the highest risk for development of anal cancer are HIV positive men who have sex with men (MSM), showing a RR of 59.5.[3] Although many individuals who are infected with HPV spontaneously clear the virus without showing any symptoms, those infected with HIV are at increased risk of persistent HPV infection and, therefore, at increased risk for anal cancer.[4] The most recent report by the CDC stated an HIV incidence rate of 44.3 (per 100,000) for African Americans compared with 5.3 for Caucasians. Furthermore, 70% of new infections were attributed to male-to-male sexual intercourse and injection drug use.[5] Moreover, between 2000 and 2011, the RR for anal cancer in black patients <30 years old was reported to be 4.56 when compared with non-Hispanic white patients of similar age.[6] Black race has also been consistently reported as a poor prognostic factor for the survival of anal cancer patients. Between 1973 and 2000, 5-year relative survival in black men decreased from 45% to 27%, whereas survival rates increased for white men and women.[2] Multivariate analysis of anal cancer cases between 1973 and 2012 identified black race as being an independent predictor of lower survival.[7,8] Yet, the effect of socioeconomic status was not evaluated in these studies. The rising incidence of SCCA in the young male population, coupled with decreased survival in black men, raises significant concern for this population. It is necessary to identify any associated social factors that could be responsible for this racial disparity, to optimize outreach efforts. The aim of this study is to determine the effect of socioeconomic variables such as median family income and rural–urban continuum on incidence and survival in young men, as they are disproportionately at risk for SCCA. Further understanding of these variables will allow for better delineation of those most at risk, allowing for improved medical education outreach. Data from the Surveillance, Epidemiology and End Results (SEER) database will be analyzed to address this hypothesis.

Methods

After exemption from institutional review board approval was obtained, the SEER data set was queried for male patients, 18–49 years old, with histologically confirmed SCCA as their only cancer diagnosis between the years of 2000 and 2013, chosen to best correspond to census data on median family income. Cases were excluded if race was unknown, disease was unstaged, microscopic confirmation was not present, or if they were not actively followed in the database. Anal cancer was defined using the International Classification of Diseases for Oncology version 3 (ICD-0-3) site codes C21.0, C21.1, and C21.8. Squamous cell carcinoma was defined by SEER histology codes 8070–8078. Stage was defined using SEER definitions of in situ, localized, regional, and distant disease. Incidence rates were standardized to the 2000 U.S. standard population. RR was calculated using incidence rate ratios. Cumulative expected survival rates were calculated using the Ederer II method, and relative age standardized survival rates were calculated using the actuarial method. Stage was evaluated according to the SEER-defined staging variable: summary stage 2000 (1998+). Median family income was determined on a county attribute level, based on data obtained from the Census American Community Survey 5-year files. Rural–urban category was determined using the United States Department of Agriculture Rural-Urban continuum codes. SEER*Stat version 8.3.4 and SPSS version 24.0.0.0 were used for Mann–Whitney U tests, Cox Proportional Hazards Survival functions using 95% confidence intervals (CI), and p values of 0.05 to determine statistical significance.

Results

A total of 28,420 cases of cancer located in the anus, anal canal, and anorectum between 2000 and 2013 were identified in the SEER database. Of these, 21,425 were microscopically confirmed squamous cell carcinoma according to histology codes and 10,963 cases were men. Of these men, 5209 were <50 years old, and after excluding cases of unknown race and stage, 4679 men were identified with SCCA between 2000 and 2013. In the final sample, 78.5% of patients were white, 18.0% were black, and 65.5% of cases were men aged 40–49 years. The incidence in black men aged 35–49 years was 4.393 compared with 3.136 in white men (p<0.001), representing a rate ratio of 1.401. The incidence in black men <35 years was 0.505 compared with 0.246 in white men (p<0.001), representing a rate ratio of 2.052. On presentation, black men had more advanced disease than white men. Incidence rates by stage and rate ratios with respect to race are presented in Table 1. The incidence of in situ disease in patients residing in metropolitan areas was nearly four times higher than that of any other stage or residential location (Table 2).
Table 1.

Incidence Rates and Rate Ratios of Squamous Cell Carcinoma of the Anus by Race, Stratified by Stage, in White and Black Males <50 Years Old, 2000–2013

 BlackWhite  
StageNRateNRateB:W rate Ratiop
In situ4710.97825640.8271.180.001
Localized1970.4226960.2241.89<0.001
Regional1370.2933340.1072.73<0.001
Distant350.073810.0262.80<0.001

Rates are per 100,000 and age adjusted to the 2000 U.S. standard population.

Table 2.

Incidence Rates of Squamous Cell Carcinoma of the Anus by Rural–Urban Continuum Stratified by Stage, in Males <49 Years Old, 2000–2013

Rural–urban categoryStageNRateConfidence interval
Metropolitan countiesIn situ30900.8430.813–0.873
Localized8450.2320.217–0.249
Regional4580.1260.114–0.138
Distant1090.0290.024–0.035
Non-Metropolitan countiesIn situ740.2030.160–0.255
Localized660.1740.135–0.222
Regional250.0670.044–0.100
Distant120.0310.016–0.055

Rates are per 100,000 and age-adjusted to the 2000 U.S. standard population.

Incidence Rates and Rate Ratios of Squamous Cell Carcinoma of the Anus by Race, Stratified by Stage, in White and Black Males <50 Years Old, 2000–2013 Rates are per 100,000 and age adjusted to the 2000 U.S. standard population. Incidence Rates of Squamous Cell Carcinoma of the Anus by Rural–Urban Continuum Stratified by Stage, in Males <49 Years Old, 2000–2013 Rates are per 100,000 and age-adjusted to the 2000 U.S. standard population. The 5-year relative age standardized survival was significantly lower for black men <50 years old (0.738, CI 0.696–0.776) than for white men (0.870, CI 0.855–0.884). Although there is a general decrease in survival with more progressive stages of disease, a significant racial disparity was identified among patients with in situ and localized disease. White men had significantly higher 5-year survival with in situ (0.954 vs. 0.892, p<0.05) and localized disease (0.791 vs. 0.628, p<0.05) than black men. White men in the highest two income quintiles had significantly improved 5-year survival across all stages than black men (Fig. 1).

Five-year age-standardized survival for males <49 years old, with squamous cell carcinoma of the anus, 2000–2013, by median family income (* denotes a statistically significant difference between white and black confidence intervals).

Five-year age-standardized survival for males <49 years old, with squamous cell carcinoma of the anus, 2000–2013, by median family income (* denotes a statistically significant difference between white and black confidence intervals). Based on the Cox Proportional Hazards model, black race was a poor prognostic factor for survival independent of stage, age, median family income, and rural–urban category (Table 3). Higher median family income was protective for survival, with each increase in median family income of $10,000 associated with a 10% benefit to overall survival. Advanced stage significantly affected survival with localized, regional, and distant stages having significantly lower overall survival than in situ disease. Age and metropolitan residence did not significantly affect overall survival. The survival function curve based on the Cox regression model illustrates the significantly lower survival associated with black race when adjusted for median family income and stage (Fig. 2).
Table 3.

Cox Regression Model for Determinants of Survival in Male Patients <50 Years Old with Squamous Cell Carcinoma of the Anus

 Hazard ratioConfidence interval
Race  
 White (ref)1
 Black1.5561.332–1.817
Stage
In situ1
 Localized2.9012.438–3.454
 Regional5.5724.648–6.678
 Distant14.43611.182–18.636
Median family income[a]0.9010.862–0.943
Age1.0560.993–1.123
Rural–urban[b]1.0610.789–1.426

Median family income variable was defined by increments of $10,000.

Rural–urban category compares hazard ratio of cases in nonmetropolitan counties with those in metropolitan counties.

Cox regression survival function for race, adjusted for stage, and median family income.

Cox regression survival function for race, adjusted for stage, and median family income. Cox Regression Model for Determinants of Survival in Male Patients <50 Years Old with Squamous Cell Carcinoma of the Anus Median family income variable was defined by increments of $10,000. Rural–urban category compares hazard ratio of cases in nonmetropolitan counties with those in metropolitan counties.

Discussion

The data demonstrate increased incidence of later stage disease in SCCA among black men than among white men, with nearly three times as many black men diagnosed with regional and distant disease at the time of presentation. Differences in the prevalence of HIV infection with respect to race is likely a major contributor to the racial disparity seen in the incidence of SCCA.[5] Prior research indicates that elevated HIV rates among black MSM can be explained by high rates of undiagnosed seropositivity, high rates of sexually transmitted infections, low use of antiretroviral therapy (ART), and low adherence to ART.[9] These factors likely apply to the incidence patterns observed here in SCCA. The CDC identifies inadequate HIV prevention education and interventions, limited awareness of infection, low perception of risk, alcohol and illegal drug use, and feelings of rejection and isolation as factors that may be contributing to the increased burden of HIV infection in this population.[10] As HIV and SCCA are intimately related, addressing these factors through culturally sensitive education would likely decrease SCCA incidence. We observed significantly higher incidence of overall disease, as well as a large shift toward diagnosis at earlier stages in metropolitan counties than nonmetropolitan counties. Similarly, McKenney et al. have shown decreased incidence of HIV in MSM in rural areas but worse outcomes. They attribute this to the lack of culturally appropriate outreach and prevention.[11] A recent study of 1907 men (901 HIV+) from four major metropolitan areas identified a number of factors significantly associated with increased intention to seek screening. These factors included any history of anal condyloma, awareness of available screening in the community, current possession of health insurance, or current HIV infection.[12] Studies specifically evaluating the barriers to screening for anal cancer among MSM cite unique barriers such as a lack of awareness of the disease in the patient, as well as a lack of healthcare recommendations to screen. They suggest an emphasis on healthcare literacy among at-risk groups to empower them to prevent cancer, more training for healthcare professionals, specifically those who routinely treat at-risk patients, and the development of national guidelines to promote anal dysplasia screening.[13] Improved education surrounding the use of the HPV vaccination would also serve to decrease incidence of SCCA. The HPV vaccine is recommended for all men up to age 21 years, and through age 26 years for MSM. Yet, actual vaccination rates are dismal ranging from 4.9% to 21% in ages 18–26 years. A key barrier to vaccination is the stigma surrounding asking for the vaccine, as youths feel it may identify them as promiscuous.[14] Providers need to proactively address possible stigma to better educate their patients on the benefits of vaccination. This would serve to improve vaccination rates, thereby decreasing incidence of SCCA. Yet, incidence is only half of the battle. The significant racial disparity in survival between young men in this study was independent of county level income and stage of diagnosis. After adjustment for stage and median family income, black men continued to have lower survival than white men. Although many studies have identified treatment interventions that work in black MSM with HIV, very few have analyzed why outreach to black MSM with HIV tends to fall short.[15] It is reasonable to assume that similar limitations apply when treating SCCA in black MSM, which would explain the lower observed survival seen in the regression analysis. Willeford et al. have noted significantly less follow-up with young black men, which is associated with higher rates of high-grade anal dysplasia.[16] Failure to follow up with SCCA would also lead to lower survival. Structural barriers, including stigma, racism, incarceration, and other barriers to care, have a significant impact on black men seeking healthcare.[17] These barriers have been studied extensively in the realm of HIV treatment, and the conclusions are directly attributable to the health disparity in SCCA. Addressing the stigma surrounding MSM and anal health, in general, would serve to improve survival. Many young men feel stigmatized about their sexual practices, and anal health, in general, which lends to avoidance of the healthcare system.[18] Community outreach programs would lead to earlier diagnosis and improved survival in SCCA, as was seen in the San Francisco SEER registry after implementation of new screening programs.[5] Further research on the comparative effectiveness of culturally specific screening and health educational programs with respect to anal health would further improve outcomes in SCCA. The limitations of this study include the inability to determine HIV status of individual patients within the SEER database, therefore, the effect of HIV prevalence on incidence and survival cannot be analyzed. Second, insurance status is not available in the SEER database, which may affect the likelihood of a patient to seek medical care. Third, income and geographic location are generalized to counties, and do not equally affect all patients living within that county. This limits the direct implication of county-level income on individual mortality. However, county income inequality is a significant determinant of health and controlling for it in regression analysis lends power to other factors such as race, and allows for the development of health improvement strategies that are applicable across the United States.[19]

Conclusions

Black race remains a poor prognostic indicator of survival of SCCA, even after controlling for median family income and stage. The health inequity identified here for diagnosis and treatment of SCCA likely parallels that studied for HIV, and using similar approaches to address this would greatly improve incidence and survival in SCCA. Improved screening protocols would identify SCCA at earlier stages and improve overall survival in at-risk populations. We advocate for an expansion of screening protocols across the United States, with an emphasis on at-risk populations across all races. But, special emphasis should be placed on developing culturally sensitive programs designed for young black men, as this was shown to be a poor prognostic indicator. Patients will further benefit from proactive physicians who openly talk about anal health, HPV vaccination, and regular screening to create a safe space in their clinics for all patients.
  18 in total

1.  Stigma and sexual health risk in HIV-positive African American young men who have sex with men.

Authors:  Jerilynn Radcliffe; Nathan Doty; Linda A Hawkins; Clare S Gaskins; Rinad Beidas; Bret J Rudy
Journal:  AIDS Patient Care STDS       Date:  2010-08       Impact factor: 5.078

Review 2.  Understanding structural barriers to accessing HIV testing and prevention services among black men who have sex with men (BMSM) in the United States.

Authors:  Matthew E Levy; Leo Wilton; Gregory Phillips; Sara Nelson Glick; Irene Kuo; Russell A Brewer; Ayana Elliott; Christopher Watson; Manya Magnus
Journal:  AIDS Behav       Date:  2014-05

3.  Impact of Income Inequality on the Nation's Health.

Authors:  Diego B López; Andrew P Loehrer; David C Chang
Journal:  J Am Coll Surg       Date:  2016-07-25       Impact factor: 6.113

4.  Understanding disparities in HIV infection between black and white MSM in the United States.

Authors:  Alexandra M Oster; Ryan E Wiegand; Catlainn Sionean; Isa J Miles; Peter E Thomas; Lehida Melendez-Morales; Binh C Le; Gregorio A Millett
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

Review 5.  Emerging viral STIs among HIV-positive men who have sex with men: the era of hepatitis C virus and human papillomavirus.

Authors:  Thijs Jw van de Laar; Olivier Richel
Journal:  Sex Transm Infect       Date:  2016-10-27       Impact factor: 3.519

6.  Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012).

Authors:  Ellen Kim; Jong S Kim; Mehee Choi; Charles R Thomas
Journal:  Dis Colon Rectum       Date:  2016-04       Impact factor: 4.585

7.  Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior.

Authors:  Meredith S Shiels; Aimée R Kreimer; Anna E Coghill; Teresa M Darragh; Susan S Devesa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-29       Impact factor: 4.254

8.  Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.

Authors:  Cristina Metildi; Elisabeth C McLemore; Thuy Tran; David Chang; Bard Cosman; Sonia L Ramamoorthy; Sidney L Saltzstein; Georgia Robins Sadler
Journal:  Am Surg       Date:  2013-10       Impact factor: 0.688

9.  HIV Risk Behaviors and Utilization of Prevention Services, Urban and Rural Men Who Have Sex with Men in the United States: Results from a National Online Survey.

Authors:  Jennie McKenney; Patrick S Sullivan; Kristina E Bowles; Emeka Oraka; Travis H Sanchez; Elizabeth DiNenno
Journal:  AIDS Behav       Date:  2018-07

10.  Anal cancer incidence and survival: comparing the greater San-Francisco bay area to other SEER cancer registries.

Authors:  E Susan Amirian; Paul A Fickey; Michael E Scheurer; Elizabeth Y Chiao
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more
  4 in total

1.  Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database.

Authors:  Shelly X Bian; Dennis H Chen; Eugene Lin
Journal:  Cancer Med       Date:  2020-12-11       Impact factor: 4.452

2.  Predisposing, Enabling, and Need-Related Factors Associated with Human Papillomavirus Vaccination Intentions and Uptake Among Black and Hispanic Sexual and Gender Diverse Adults in the USA.

Authors:  Christopher W Wheldon; Lisa A Eaton; Ryan J Watson
Journal:  J Racial Ethn Health Disparities       Date:  2022-01-03

3.  Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma.

Authors:  Suleyman Y Goksu; Muhammet Ozer; Syed M A Kazmi; Todd A Aguilera; Chul Ahn; David Hsiehchen; Aravind Sanjeevaiah; Mary C Maxwell; Muhammad S Beg; Nina N Sanford
Journal:  Am J Clin Oncol       Date:  2020-11       Impact factor: 2.787

4.  Disparities in the Epidemiology of Anal Cancer: A Cross-Sectional Time Series.

Authors:  Carlos R Oliveira; Yu S Niu; Hulda M Einarsdottir; Linda M Niccolai; Eugene D Shapiro
Journal:  Health Equity       Date:  2020-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.